On Jan. 04, Augusti Mark A divested U.S. $63,287 in shares of Conformis Inc.. The Pres, CEO sold 93,285 shares at a price per share of $0.68. The transaction decreased this specific insider’s holdings to 2,248,085 shares worth around $1.69 million at present.
BTIG Research took its Conformis Inc. [CFMS] rating to the equivalent of a Neutral from a Buy, in a research note dated August 01, 2019. Other analysts also revised their coverage, with BTIG Research’s analysts downgrading the shares from “a Buy” rating to “a Neutral” rating in a research note to investors issued in early August. Meanwhile, JP Morgan had lowered its rating on CFMS to “an Underweight” from the earlier “Neutral”, in a research note produced for clients January 02, 2018. In addition, there was an upgrade from BTIG Research on December 20, 2017. The rater changed CFMS from “a Neutral” to “a Buy”.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Is Conformis Inc. [NASDAQ:CFMS] a Good Buy Right Now?
It should be noted that CFMS technical indicators for short, intermediate as well as long term progress have placed an overall average of 8% as Sell. The average signal changed from 56% Sell in the last week and compares with 88% Sell in the past month. Data from Conformis Inc.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 3.83 million shares in the past 20 days and the short term average signal indicates a Hold. In the last 50 days, the average trading volume was 1.74 million shares while the medium term average advocated for 50% Sell. The average long-term signal stands at Hold and the 100-day average volume stands at 1.09 million shares.
CFMS Price Performance
On Wall Street, Conformis Inc. [NASDAQ:CFMS] finished Wednesday’s session up 0.39% at $0.75. The stock went up to $0.8899 at the same session while its lowest single day price was $0.7236. In the last five days, it saw a rise of about 6.78%, Conformis Inc. shares gained by almost 14.08% since the beginning of the year. However, the share price has dropped to as low as -53.52% below its one year high. On 01/06/21, the company shares recorded $0.8899, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $0.6400. The company’s shares have declined by -51.43% in the past year. The 50-day SMA achieved is $0.6679 while the 200-day SMA is $0.7593. Volume gained to 9.36 million from 8.82 million in the previous session.
CFMS Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 0.6877 level, and in case of violation of this particular level, it will cause more drop to 0.6225 level. On the upper level, 0.9551 is still the key resistance. The stock may increase to the subsequent resistance at 0.8540. The Relative Strength Index (RSI) pinned on the 14-day chart is 60.80, implying a neutral technical stance while the MACD stands at 0.0348, meaning price will decrease in the next trading period. Percent R indicator moved to 54.95%, implying low price movement. Stochastic %K at 34.20% suggest holding the stock.
What is the short interest in Conformis Inc.?
Short interest in the Conformis Inc. stock has surged, increasing by 28650.0 shares to total 0.48 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 0.51 million, data from Yahoo Finance shows. The decrease of -5.93% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 0.57% of the overall float for the stock.
Conformis Inc.’s Biggest Shareholders: Who Owns Conformis Inc. [CFMS]?
Filings by Armistice Capital LLC showed that the firm now holds a total of 7,477,385 shares or roughly 8.70% of the outstanding CFMS shares. Details in the latest 13F filings reveal that Archon Capital Management LLC disposed off their -10.74% stake valued at $2,474,172 while The Vanguard Group, Inc. cut theirs at $1,942,183. During the last quarter, Archon Capital Management LLC liquidated -464,498 of its shares in Conformis Inc. while The Vanguard Group, Inc. sold -7,457 shares. The BlackRock Fund Advisors’s holdings currently number 1,171,347 shares at $878510.25. According to the firm’s last 13F report, Millennium Management LLC shares in the company at filing stood at 954,099 shares, roughly $611,577.
CFMS Earnings Forecast For The Current Quarter
Conformis Inc. [CFMS] is expected to report weak earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $18.23M and an earnings per share of -$0.09 for Dec 2020. Looking further ahead, the company is expected to report revenue of $18.29M at an EPS of -$0.08 for Mar 2021. The estimates represent downside of 13.00% and 2.90% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
CFMS Earnings Estimates For The Current Year
For the financial year, Conformis Inc. [NASDAQ:CFMS] is expected to bring in revenue of $70.45M. The returns are nearly $-6.98 million lower than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at -0.35, higher than that of FY19 by $0.09. Estimates put this year’s earnings growth at 20.50%, 2.90% for the next, and at an annual -14.58% over the next 5-year period. As for sales, forecasts are for a decrease of -9.00% in the current fiscal year and a further 13.00% over the following year.
What are analyst thoughts on Conformis Inc.?
Looking forward to the Conformis Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Conformis Inc. stock at $2.00 within the next 12 months, which represents almost 62.5 per cent growth from its previous closing price of $0.75. The highest analysts’ target for Conformis Inc. stock projections is $3.00 and the lowest one is $2.00. Still, 4 analysts sharing their consensus rating for CFMS stock in 2021 agree that it is an Overweight.